From medication access to adherence challenges, social vulnerability can shape diabetes outcomes. In this expert Q&A, Dr. Mary Elizabeth Patti reviews evidence showing that metabolic surgery delivers...
April 2026 included several FDA drug and biologic approvals across a range of therapeutic areas. This timeline highlights the key alerts our publication covered throughout the month, giving readers a quick,...
Although pharmacologic management remains central for treating metabolic syndrome, modifiable behavioral patterns are increasingly important in risk reduction counseling.
How does excess weight influence the risk of lingering neuropsychiatric symptoms after COVID-19? Test your knowledge of the link between body weight and the nervous system’s response to infections.
With broader availability, adults with prediabetes and even those simply seeking health insights can now track glucose trends in real time—empowering earlier interventions, self-discovery, and more...
A recent study explored blood pressure reduction in midlife men and women. Which group showed the greatest improvement? Test your knowledge in our quiz!
From medication access to adherence challenges, social vulnerability can shape diabetes outcomes. In this expert Q&A, Dr. Mary Elizabeth Patti reviews evidence showing that metabolic surgery delivers...
GLP-1 medications are reshaping patient expectations. In this podcast, learn how dietitians guide safe, evidence-based care amid rising demand and misinformation.
In this Nutrition 411 podcast, experts unpack the updated pyramid, highlighting minimal changes and how dietitians can address confusion and misinformation.
Lisa Jones, MA, RDN, LDN, FAND; Bonnie Chambers, MSN, FNP-C
This episode of Nutrition411 explores how clinicians and dietitians can set realistic, emotionally informed expectations for patients using GLP-1 medications for obesity.